GOLDMAN SACHS GROUP INC bought ATTO
August 6, 2026 · Form 4 insider transaction
GOLDMAN SACHS GROUP INC bought 500,000 shares of Attovia Therapeutics, Inc. at $17.00 per share, a transaction worth $8.50M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 7 days after the transaction.
Footnotes
The previous report on Form 3 reflected an administrative error with respect to the number of shares of common stock issuable upon conversion of the Preferred Stock, which is corrected in this Form 4.; Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that any such Reporting Person is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.; These transactions in the common stock of the Issuer were effected by Goldman Sachs & Co. LLC ("GS&Co") acting as a market maker in the ordinary course of business. Without conceding market making trades in the ordinary course of business can result in liability under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that they were subject to Section 16(b) will be remitted to the Issuer.